According to IMARC Group’s latest report, titled “mRNA Vaccines and Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” Offers a comprehensive analysis of the industry, which comprises insights on mRNA vaccines and therapeutics market.
The global mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022. Messenger ribonucleic acid or mRNA vaccines and therapeutics refer to types of vaccines and formulations that use a copy of a molecule, known as messenger RNA, to create an immune response. They are of several types, including self-amplifying, in vivo self-replicating, non-replicating, in vitro dendritic cell non-replicating mRNA, etc. mRNA vaccines and therapeutics combine the desirable immunological properties and are produced in laboratories employing mammalian cells. They trigger virus-detecting immune sensors and build viral antigen proteins within the cells when injected into the body, thereby enhancing the body’s immunity by improving B- and T-cell responses. As a result, mRNA vaccines and therapeutics find extensive utilization in hospitals, clinics, and research organizations across countries.
Request Free Sample Report: https://www.imarcgroup.com/mrna-vaccines-therapeutics-market/requestsample
Market Trends
The expanding prevalence of diabetes, cancer, tuberculosis, cardiovascular diseases (CVDs), etc., is among the key factors driving the global mRNA vaccines and therapeutics market. In addition to this, the escalating demand for effective medicines and treatments for influenza, Ebola, Human Immunodeficiency Virus (HIV), etc., is also positively influencing the market growth. Moreover, the increasing enhancements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are acting as another significant growth-inducing factor. In line with this, the inflating investments by leading pharmaceutical companies in mRNA technologies that can combine multiple molecules into a therapeutic medicine are further stimulating the market growth. Apart from this, the elevating research and development (R&D) projects in the field of biotechnology and the growing improvements in healthcare technologies are anticipated to fuel the global mRNA vaccines and therapeutics market over the forecasted period. Looking forward, IMARC Group expects the market to reach US$ 66.2 Billion by 2028, exhibiting a growth rate (CAGR) of 2.9% during 2023-2028.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/mrna-vaccines-therapeutics-market
The report has segmented the market on the basis of vaccine type, treatment type, vaccine manufacturing, application, end-user and geography.
Breakup by Vaccine Type:
- Self-amplifying mRNA-Based Vaccines
- Conventional Non-Amplifying mRNA-Based Vaccines
Breakup by Treatment Type:
- Bioengineered Vaccine
- Gene Therapy
- Gene Transcription
- Cell Therapy
- Monoclonal Antibody
- Others
Breakup by Vaccine Manufacturing:
- In-House
- Out-Sourced
Breakup by Application:
- Cancer
- Infectious Disease
- Gene Editing
- Protein Replacement
Breakup by End-User:
- Hospitals and Clinics
- Research Organizations
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Arcturus Therapeutics Inc., BioNTech SE, CureVac AG, eTheRNA immunotherapies NV, ethris GmbH, GlaxoSmithKline PLC, Moderna Therapeutics Inc., Translate Bio Inc., Argos Therapeutics, Inc., Sangamo Therapeutics Inc. and Pfizer Inc, etc.
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800